Art

J-GLOBAL ID：200902289130859030   Reference number：05A0749846

Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b⁺ HLA-A24⁺ patients

HCV1b+ HLA-A24+患者における細胞性および液性免疫系の両方で認めたC型肝炎ウイルス1b誘導ペプチドの同定

Author (13)： TAMURA Mayumi (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  YAMADA Akira (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  YAMADA Akira (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...) ,  TAKAO Yukari (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  TAKAO Yukari (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  MATSUEDA Satoko (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  KOMATSU Nobukazu (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  KOMATSU Nobukazu (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...) ,  YUTANI Shigeru (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  IDE Tatsuya (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  SATA Michio (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  ITOH Kyogo (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  ITOH Kyogo (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...)
Material： Hepatology Research  (Hepatol Res)
Volume： 32  Issue： 4  Page： 227-234  Publication year： Aug. 2005 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： HCV1b ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0749846&from=J-GLOBAL&jstjournalNo=W1284A") }}

JST classification (2)： Treatment for digestive system diseases in general  (GH05010V) ,  Proteins and peptides in general  (EB03010N)

Reference (18)：

• World Health Organization. Hepatitis C gloval prevalence (update). World Health Org Wkly Epidemil Rec. 2000, 75, 18-19
• KATO, N. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 1990, 87, 9524-9528
• BLATT, LM. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat. 2000, 7, 196-202
• TAKAO, Y. Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of including HLA-A2 restricted cytotoxic T lymphocytes is detectable in the majority of HCV-infected individuals without HLA-A2 restriction. Microbiol Immunol. 2004, 48, 507-517
• ITO, M. Identification of SRAT3-derived peptides capable of inducing HLA-A24-restricted and tumor-specific CTLs in cancer patients with different HLA-A24 subtypes. Int J Cancer. 2000, 88, 633-639

Terms in the title (7)： 患者 ,  細胞性 ,  液性免疫 ,  C型肝炎ウイルス1b ,  誘導 ,  ペプチド ,  同定